STRIDEBIO INC has a total of 32 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets biotechnology and pharmaceuticals are NEW PORTAL LTD, ROCKET PHARMACEUTICALS LTD and ASKLEPIOS BIOPHARMACEUTICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Israel | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Singapore | 3 | |
#9 | Taiwan | 2 | |
#10 | China | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mccoy Daniel | 26 |
#2 | Berry Garrett E | 25 |
#3 | Smith James Kennon | 7 |
#4 | Dismuke David | 5 |
#5 | Garrett E Berry | 3 |
#6 | Daniel Mccoy | 3 |
#7 | Thomas Darby | 2 |
#8 | Berry Garrett | 1 |
#9 | James Kennon Smith | 1 |
Publication | Filing date | Title |
---|---|---|
US2021115474A1 | Adeno-associated viral vectors for treatment of niemann-pick disease type-c | |
WO2021076911A1 | Aav transfer cassette | |
WO2020191300A1 | Recombinant adeno-associated virus vectors | |
WO2020106916A1 | Recombinant viral vectors and nucleic acids for producing the same | |
BR112020020195A2 | VIRUSES WITH ANTIBODY EVASION | |
AU2019247748A1 | Antibody-evading virus vectors | |
CA3094465A1 | Virus vectors for targeting ophthalmic tissues |